Actively Recruiting

Age: 65Years +
All Genders
ID07180368

Assessment and Management of Multiple Drug Use in Elderly Patients with Chronic Diseases

Led by Xijing Hospital · Updated on 2025-09-18

2000

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand how taking multiple medications, known as polypharmacy, affects the health outlook of elderly patients who have chronic diseases. It focuses on patients aged 65 years or older living with conditions such as coronary artery disease, diabetes, chronic kidney disease, hypertension, heart failure, hyperlipidemia, obesity, chronic obstructive pulmonary disease (COPD), or stroke. The study is observational and conducted by Xijing Hospital. Participants will complete online surveys over a two-year period to report on their disease progression and medication use. This approach helps researchers gather information without providing any specific treatment or intervention. The surveys are designed to assess the current state of polypharmacy in this patient group. Throughout the study, researchers will monitor participants’ responses to understand how multiple drug use influences their prognosis. The main outcome measured is the status of polypharmacy from enrollment through the end of the two-year study. By collecting this data, the study aims to provide insights into medication management for elderly patients with chronic illnesses.

CONDITIONS

Brief Title

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 65 years or older with at least one chronic disease
Not Eligible

You will not qualify if you...

  • Patients without chronic diseases
  • Patients who refuse to participate in the study
  • Patients with unstable vital signs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 2 years

Participants are observed to assess the current status of multiple drug use in elderly patients with chronic diseases.

Periodic visits depending on participant availability

Trial Site Locations

Total: 1 location

1

Xijing Hospital

Xi'an, Shaanxi, China, 710032

Actively Recruiting

Loading map...

Research Team

M

Ming Yuan, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

"Smart Family Doctor" Assisted Comprehensive Management of S...

Post Coronary Artery Bypass Grafting

Actively Recruiting

1 location

The PILI 'Aina Project to Improve Cardiometabolic Health in...

Type 2 Diabetes

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here